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ABSTRACT 
 
The development of cranial bones and palate are complex processes where the 
development of multiple elements needs to be coordinated spatiotemporally to produce a 
working unit such as calvarium, cranial base, or palate. I have shown here that a common 
theme in the early development of craniofacial structures is balancing the level of 
proliferation and differentiation of progenitor cell populations by growth factor signalling 
so that large enough population of progenitor cells is formed before differentiation, or that 
proliferation is maintained for the outgrowth of the element. 
 Here I show that a reduced proliferation of osteoprogenitor cells in mice lacking a 
forkhead/winged helix transcription factor Foxc1 prevents the outgrowth of calvarial 
bones. I further demonstrate that Foxc1 is required for bone morphogenetic protein (Bmp) 
regulation of Msx2 and Alx4 to maintain this proliferation. 
 Fibroblast growth factor (Fgf) signalling also plays an important role in regulating 
the proliferation of progenitor cell populations during craniofacial development as shown 
here by the expression patterns of different Fgf receptor isoforms in the proliferative 
osteoprogenitor cells in calvarial sutures, and in the proliferative chondrocytes in the 
cranial base synchondroses and mandibular condyles. Furthermore, I show that reiterative 
Fgf signalling between palatal shelf epithelium and mesenchyme is essential for 
maintaining proliferation and cell survival in these tissues to ensure outgrowth and 
morphogenesis of the palatal shelves. 
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INTRODUCTION 
 
The hard tissues in the head, the bones, cartilages, and teeth, play many essential roles for 
our survival. Calvarial and cranial base bones protect the brain and sense organs from 
external shocks. Three small bones in the inner ear are needed for us to hear. Jaws allow 
us to talk, and together with teeth they enable us to chew. Palate works as a barrier 
between mouth and nose, thus ensuring that we can eat and breathe at the same time. 
The craniofacial skeleton differs from the axial and appendicular skeleton in many 
aspects. The craniofacial skeleton is derived from both cranial neural crest and paraxial 
mesoderm while the axial skeleton is of paraxial mesoderm origin. During development 
cranial bones use both endochondral and intramembranous ossification, but the only 
intramembranous bones in the axial skeleton are the medial parts of the clavicles (Huang 
et al., 1997). Also, secondary cartilages are not found in the axial skeleton. Sutures and 
synchondrosis are only part of the craniofacial skeleton. They function as fibrous joints 
between adjacent skeletal elements; sutures between intramembranous flat bones, and 
synchondrosis between cranial base endochondral bones. Calvarial and cranial base bones 
are unique in being in contact with the meninges covering the brain. 
On a molecular level, an important difference between craniofacial and axial and 
appendicular skeleton is the Hox code. It is needed for the anterior-posterior patterning 
and positional identity of the axial and appendicular skeleton. But Hox genes are 
primarily not expressed in craniofacial regions forming skeletal elements (Whiting, 1997). 
Interestingly, Creuzet et al. (2002) showed that it is essential for the development of the 
facial skeleton to stay Hox negative. A reverse is true too: downregulation of Hox genes 
in a subset of trunk neural crest cells allows these cells to produce chondrocytes that they 
normally do not generate (Abzhanov et al., 2003). Hox genes contributing to the 
craniofacial skeleton are those expressed in the occipital somites and the 2nd branchial 
arch. Therefore, Hox code contributes to the posterior cranial base and lower face, 
respectively. 
Despite its differences, craniofacial skeletal development requires the same set of 
basic developmental signals as other developing tissues. Studies in tooth, mandible, 
palate, and calvarium models have shed light onto the importance of epithelial-
mesenchymal tissue interactions that guide the morphogenesis and growth of many 
tissues. The bone morphogenetic (Bmp), fibroblast growth factor (Fgf), Wingless (Wnt), 
and hedgehog (Hh) signalling pathways interact in the formation of a tooth (reviewed in 
Jernvall and Thesleff, 2000). Similarly, Bmp, Fgf, and Hh pathways have been shown to 
interact in the calvarial suture development to regulate ossification (Kim et al., 1998; Iseki 
et al., 1999; Rice et al., 2000). It seems that it is the spatiotemporal activation of a specific 
set of transcription factors by growth factor signalling molecules that determine the 
differentiation and growth of tissues. 
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REVIEW OF THE LITERATURE 
 
The origins of craniofacial structures 
The skeletal elements of the skull are derived from mesoderm and cranial neural crest 
(CNC). CNC cells originate from the neural epithelium in the neural folds. These cells 
undergo epithelial-to-mesenchymal transition, and migrate to their final destinations in the 
neck and craniofacial regions (Trainor and Nieto, 2003). In avian, quail-chick chimaeras 
have allowed detailed studies of the fate of CNC cells (Noden, 1983; Couly et al., 1993; 
Huang et al., 2000) These studies have demonstrated that the facial skeleton and anterior 
cranial base are entirely of cranial neural crest origin, and that the posterior cranial base 
skeleton is derived from paraxial and somitic mesoderm (Huang et al., 2000). 
 
The origin of calvarium 
The origin of calvarial tissue layers has remained debatable. In the developing 
chick, Noden (1986) showed that intramembranous skull bones, their periosteum and 
sutures are derived from paraxial mesoderm, and that the underlying dura mater is derived 
from CNC cells. On the other hand, Couly et al. (1992, 1993) showed that all tissues in 
the calvarium are from early migratory populations of cranial neural crest cells. Thus, we 
can safely say that at least dura mater is derived from the neural crest in the calvarium of 
the avian. In mouse, CNC cell destinations have been studied by histological analysis of 
early embryos and DiI-labeling experiments (Nichols 1981; Serbedzija et al., 1992; 
Osumi-Yamashita et al., 1994). The techniques used in these studies have allowed a 
detailed study of the migratory pathways of neural crest cells. Similarly to chick, mouse 
cranial neural crest cells populate the first, second, and third branchial arches, and the 
frontonasal mass. Therefore, CNC cells contribute to the facial structures also in the 
mouse. Recently, the creation of a transgenic mouse Wnt1-Cre/R26R, which carries a 
permanent neural crest cell lineage marker, allowed the analysis of the origin of 
mesenchymal tissues in the mouse cranium (Jiang et al., 2002). The authors showed that 
the alisphenoid, squamosal, and frontal bones of the calvarium, the metopic suture 
mesenchyme between the frontal bones, and the meninges underlying them are of cranial 
neural crest origin. They also showed that the sagittal suture mesenchyme between the 
parietal bones and the dura mater underneath these bones are of neural crest origin. The 
parietal bones themselves and the meninges covering the mid- and hindbrain are of 
mesodermal origin. The interparietal bone was shown to be of dual origin: the medial part 
of the bone is derived from the neural crest while the lateral parts are mesodermal. Thus, 
it seems that in mouse, calvarial tissue layers caudal to frontal bones arise from mesoderm 
with the exception of the meninges underneath the parietal bones. The disadvantage of 
using Wnt1-Cre/R26R mice is that Wnt1 expression is not specific to neural crest cells but 
also to parts of the brain (Jiang et al., 2002). Pietri et al. (2003) have established a 
transgenic line, the human tissue plasminogen activator-Cre mouse (Ht-PA) that targets 
specifically neural crest cells that have undergone epithelial-mesenchymal 
transdifferentiation and that are beginning to migrate. The calvarium of Ht-PA mice was 
analyzed only prior to calvarial bone formation. Thus, at the moment we do not know 
whether results from the Ht-PA mice would be comparable with the results from Wnt1-
Cre/R26R mice for the origin of calvarial tissue layers. 
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Importance of tissue origin 
Does the tissue origin matter? It becomes important when deficiencies in neural 
crest cell formation, migration or proliferation could occur. For instance when the 
transcription factor Dlx2, which is expressed in the migratory and postmigratory neural 
crest cells, is “knocked out”, the mutant embryos exhibit first and second arch defects 
(Qiu et al., 1995). 
The proposal that the origin of the embryonic mesenchyme is relatively 
unimportant is supported by the finding that as neural crest cells reach their destinations 
they have become indistinguishable from cells of mesodermal origin (Serbedzija et al., 
1992). Also, Schneider (1999) demonstrated that when midbrain level neural crest cells 
were transplanted into somitomeres 4, 5, and 6, the transplanted neural crest cells 
participated in the formation of the lateral wall of the brain case. The formed skeletal 
elements were morphologically indistinguishable from those of control embryos. Also, 
Trainor and Krumlauf (2000, 2001) have shown that mouse cranial neural crest cells have 
plasticity, and that they can be patterned by their environment. Ito et al. (2003) studied the 
role of transforming growth factor beta receptor type II (Tgfbr2) in cranial neural crest 
cell population under Wnt1 promoter. Their results demonstrated that aberrant Tgfβ 
signalling results in abnormal development of the dura mater, and that this leads to 
calvarial defects irrespective of tissue origins. Thus, it seems that the susceptibility of the 
mesenchyme to appropriate inductive signals from surrounding tissues and the presence 
of the right inductive signals can be more important than the tissue origin of craniofacial 
skeletal elements. 
 
Morphogenesis of craniofacial structures 
The development of the craniofacial structures is a complex process of patterning and 
growth of different units arising from cranial neural crest and paraxial mesoderm. The 
skull can be divided into the neurocranium, which consists of the calvarium and the 
cranial base, and the viscerocranium, which consists of the face, palate, jaws, and teeth 
(Meikle, 2002; Wilkie and Morriss-Kay, 2001). During early embryonic development the 
viscerocranium arises from five different processes. These processes grow, meet and fuse. 
The frontonasal process contributes to the formation of the nose, upper incisors, and 
primary palate. Two maxillary processes become the secondary palate, the rest of the 
upper teeth, and maxilla. Two mandibular processes develop into the mandible and 
lower teeth. The development of the neurocranium occurs as formation of localized 
chondrification/ossification centres in head mesenchyme due to local and systemic 
inductive signals. 
 
Development of the secondary palate 
The mammalian secondary palate forms as bilateral shelves from maxillary 
processes (Fig. 1). In mouse, the mesenchymal cells within the maxillary processes 
proliferate and form the palatal shelf primordia, which start to grow downwards lateral to 
the tongue at E12. Two days later the palatal shelves have begun to elevate to a horizontal 
position above the tongue. By E14.5 the shelves have met at midline and begin to fuse to 
form a single continuous palate (Ferguson, 1988). The palate epithelium can be divided 
into three regions: the nasal, oral, and medial edge epithelium (MEE). The fusion of 
palatal shelves involves adhesion, migration, apoptosis, and transdifferentiation of MEE 
cells into mesenchymal cells (Cuervo et al., 2002; Ferguson, 1988; Griffith and Hay, 
1992; Martinez-Alvarez et al., 2000; Shuler et al., 1991, 1992). 
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Figure 1. Palate development in mouse. Palatal shelves begin to develop as a bud (b) 
from maxillary processes at E12. They grow downwards next to the tongue (t), and by 
E13 palatal shelves (p) are visible. The epithelium surrounding the palatal shelf can be 
divided into oral (o), medial edge (*), and nasal (n) epithelium. At E13 the developing 
tongue depresses, and palatal shelves start to elevate. By E14 the palatal shelves have 
elevated. The hatched area indicates the continuous oral and nasal cavities before palatal 
shelves have met and fused. E17 shows a fused, continuous palate with separated oral and 
nasal cavities. m, molar tooth. 
 
 
Molecular pathogenesis of cleft palate 
A defect at any of the developmental stages can cause a cleft palate (Fig. 1b-c, k-l 
in Publication III). Cleft palate may also arise as a secondary defect. For instance, Hoxa2 
null allele mice exhibit a cleft palate due to abnormal attachment of the hyoglossus 
muscle to the greater horn of the hyoid; this does not allow depression of lateral edges of 
the tongue (Gendron-Maguire et al., 1993; Rijli et al., 1993; Barrow and Capecchi, 1999). 
Interestingly, deletion of Hoxa1 alleles in Hoxa2 null mutants restores the hyoid and 
tongue musculature connections, and rescues the cleft palate (Barrow and Capecchi, 
1999). These studies demonstrate the importance of tongue posture in the elevation of 
palatal shelves. Furthermore, ectopic expression of trunk level Hoxa7, Hoxb6, or Hoxb7, 
or of posterior hindbrain level Hoxd4, in the anterior hindbrain level leads to a cleft 
palate. It is thought that the occipital and/or basisphenoid bone abnormalities in these 
transgenic mice interfere with the elevation of the palatal shelves (reviewed in Whiting, 
1997). 
Mutations in many genes have been shown to cause clefting of the secondary 
palate in mice (Table I). Most of these mouse mutants have multiple other craniofacial 
abnormalities, and the pathogenesis of the cleft palate has not been well studied. The only 
mouse mutant that exhibits a partial or complete cleft palate that is not associated with 
other craniofacial abnormalities is transforming growth factor β3 (TGFβ3) null allele 
mice (Kaartinen et al., 1995; Proetzel et al., 1995). Kaartinen et al. (1997) later showed 
that TGFβ3 null mutants lack the initial adhesive interactions between palatal shelves, and 
10 
that the basement membrane of MEE cells is not degraded. Taya et al. (1999) showed that 
the initial adhesive interactions are abnormal due to lack of proteoglycan-rich filopodial 
structures on the surface of the MEE. Thus, transdifferentiation of the MEE cells to 
mesenchyme, which requires the adhesion of opposing MEE (Griffith and Hay, 1992) and 
the proteolytic degradation of basement membrane in midline epithelial cells (Kaartinen 
et al., 1997; Blavier et al., 2001), is deficient in these mice. Finally, Martinez-Alvarez et 
al. (2000) have shown evidence that TGFβ3 also plays a role in inducing the apoptosis of 
MEE cells during palatal shelf fusion. Furthermore, Cecconi et al. (1998) showed that 
Apaf1 mutant mice, which lack apoptosis due to disrupted caspase signalling, exhibit a 
cleft palate where palatal shelves develop and elevate normally, but fail to fuse. 
 
Table I. Mouse mutants with cleft palate. 
 
Mouse mutation Defects Molecular mechanism References 
Transcription factor    
Alx3-/-;Alx4-/- Increased apoptosis in 
frontonasal mass, abnormal 
lateral position of nasal 
processes at E10.5
 Beverdam et al., 2001 
Alx4+/-;Cart1-/-, Alx4-/-
;Cart1+/-, and Alx4-/-
;Cart1-/- 
Midline fusion defect  Qu et al., 1999 
δΕΦ1−/− Cleft palate  Takagi et al., 1998 
dHAND-/- Disruption of branchial arch 
mesenchyme
 Yanagisawa et al., 2003 
Dlx5-/- Reduced proliferation Loss of Goosegoid in 
mandible and frontonasal 
mass
Acampora et al., 1999; 
Depew et al., 1999 
Foxc2 (Mfh1)-/- Cleft palate Disrupted Shh signalling? Iida et al., 1997 
Gli2-/- Palatal shelves do not elevate  Mo et al., 1997 
Hic1-/- Small palatal shelves  Carter et al., 2000 
Hoxa2-/- Palatal shelves do not elevate 
due to tongue musculature 
defects
 Gendron-Maguire et al., 
1993; Rijli et al., 1993 
Lhx8-/- Small palatal shelves  Zhao et al., 1999 
Msx1-/- Impairment of proliferation in 
palatal mesenchyme and 
epithelial-mesenchymal 
interactions
Lack of Bmp4 expression in 
mesenchyme leads to lack of 
Shh in epithelium which leads 
to lack of Bmp2 in 
mesenchyme
Zhang et al., 2002 
Mhox-/- Cleft palate  Martin et al., 1995 
p63-/- Epithelial-mesenchymal 
interactions affected
 Mills et al., 1999, Yang et 
al., 1999 
Pax9-/- Cleft palate Required for expression of 
Bmp4, Msx1, and Lef1
Peters et al., 1998 
Pitx1-/- Palatal shelves do not elevate  Lanctot et al., 1999, Szeto 
et al., 1999 
Pitx2-/- Small palatal shelves Lack of Fgf8 expression, 
misexpression of Bmp4, 
Msx1, and Msx2
Lu et al. 1999 
Prx1-/-;Prx2-/- Small palate due to reduced 
proliferation
Control of Shh expression in 
epithelium
 ten Berge et al., 1998; Lu 
et al., 1999; ten Berge et 
al., 2001 
Rae28-/- Cleft palate Misexpression of some Hox 
genes
Takihara et al., 1997 
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Tbx1-/- Cleft palate  Jerome and Papaioannou, 
2001 
Titf2-/- Cleft palate  De Felice et al., 1998 
Growth factors and 
receptors 
   
α5−ιντεγρ ν−/− ι Small palatal shelves  Bader et al., 1998 
Activinb-A-/- Cleft palate  Matzuk et al., 1995a,b 
ALK4-/- Cleft palate  Matzuk et al., 1995a 
Efgr-/- MEE persists Metalloproteinase expression Miettinen et al., 1999 
Ephb2-/-;Ephb3-/- Small palatal shelves  Orioli et al., 1996 
ET-1-/- Epithelial-mesenchymal 
interactions affected
Lack of dHAND expression Kurihara et al., 1994, 
Yanagisawa et al., 1998 
Fgf10-/- Epithelial-mesenchymal 
interactions affected, reduced 
proliferation
Lack of Shh expression Publication III 
Fgf18-/- Failure of palatal shelf 
elevation?
 Liu et al., 2001 
Fgfr1 hypomorph Cleft palate due to tongue 
blocking palatal shelf elevation
 Trokovic et al., 2003 
Fgfr2b-/- Epithelial-mesenchymal 
interactions affected, reduced 
proliferation
Lack of Shh expression De Moerlooze et al., 2000; 
Publication III 
Follistatin-/- Small palatal shelves  Matzuk et al., 1995c 
Jagged 2-/- Palatal shelves do not elevate 
and tongue fuses with them
Disrupted Notch signalling Jiang et al., 1998a 
PDGFRa-/- (Patch 
mutant) 
Decreased neural crest 
migration, abnormal tissue 
remodelling
Decrease in MMP-2 and MT-
MMP
Morrison-Graham et al., 
1992, Robbins et al., 1999 
γΡΑΡ−/− Cleft palate  Lohnes et al., 1993 
Ryk-/- Highly positioned tongue 
obstructs elevation of one of 
the palatal shelves
Interacts with Ephb2 and b3 
receptors
Halford et al., 2000 
Shh-/- Decreased cell survival and 
proliferation, failure of midline
Lack of Tbx1 expression in 
branchial arches
Chiang et al., 1996 
TGFb2-/- Palatal shelves do not elevate  Sanford et al., 1997 
TGFb3-/- Lack of filopodia structures on 
the surface of MEE prevents 
adhesion
 Kaartinen et al., 1995, 
Proetzel et al., 1995, Taya 
et al., 1999 
Growth factor 
antagonist 
   
Chordin-/- Defects in axial mesendoderm 
and pharyngeal arches 2-6
Misexpression of Fgf8 and 
Tbx1 in pharyngial region
Bachiller et al., 2003 
Extracellular matrix 
molecule 
   
(a1) II collagen (Dmm) 
mutant 
Cleft palate Thick collagen fibrils Pace et al., 1997 
Perlecan (Hspg2)-/- Cleft palate Disorganized collagen fibrils Arikawa-Hirasawa et al., 
1999 
Intracellular molecule    
3b-hydroxysterol D7-
reductase-/- 
Small palatal shelves (cleft 
palate)
Shh signaling? Wassif et al., 2001 
Apaf1-/- No palatal shelf fusion due to 
lack of apoptosis
Blockage in caspase 
signalling
Cecconi et al., 1998, 
Honarpour et al., 2000, 
Yoshida et al., 1998 
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CASK mutant Sex linked cleft palate  Wilson et al., 1993; Laverty 
and Wilson, 1998 
IKK1-/- Cleft palate NFkB activation diminished Li et al., 1999 
p57kip2-/- Cleft palate Altered cell proliferation and 
differentiation
Zhang et al., 1997; 
Caspary et al., 1999 
Tattered (D8-D7 sterol 
isomerase) mutant 
Abnormal palatine process 
and anterior palatine foramen 
fails to join
 Derry et al., 1999 
Neurotransmitter    
GABA67-/- Palatal shelves do not fuse  Asada et al., 1997; Condie 
et al., 1997; Homanics et 
al., 1997 
 
 
 
Palatal shelf development requires epithelial-mesenchymal interactions 
The development of palatal shelves has also been shown to require epithelial-
mesenchymal interactions which suggest that also paracrine mode of regulation plays a 
role in secondary palate formation. Tyler and Pratt (1980) performed E12 mouse palatal 
cultures where they separated epithelium from underlying mesenchyme, and cultured the 
separated tissues in culture medium with or without added epidermal growth factor 
(EGF), which was known to affect epithelial cell differentiation and DNA synthesis. The 
results showed that oral and nasal regions of palatal epithelium undergo limited 
differentiation when cultured alone and without EGF. Isolated epithelial cultures with 
EGF showed some epithelial cell differentiation. Recombination of epithelium and 
mesenchyme in culture showed normal histodifferentiation of the epithelium without 
EGF. When recombinant tissues were cultured in the presence of EGF, oral and nasal 
epithelia became continuous with each other and the midline epithelium was lost. Most 
importantly, only the epithelial-mesenchymal cultures with added EGF showed DNA 
synthesis in the epithelium. This experiment was the first to indicate that epithelial-
mesenchymal interactions are needed for palatal growth; the epithelium requires 
mesenchyme to respond to the mitogenic effect of EGF (Tyler and Pratt, 1980). A few 
years later, Ferguson and Honig (1984) published a study that further supported an 
important role for epithelial-mesenchymal interactions and for their right timing during 
the development of the secondary palate. The authors performed cultures with mouse, 
chick and alligator palates and mandibles. Intraspecies recombination cultures of 
mandibular epithelium with palatal mesenchyme, and vice versa, showed that in alligator 
and chick the mesenchyme directs the epithelial cell fate: the palatal epithelium adopted 
mandibular phenotype when it was cultured with mandibular mesenchyme, and vice 
versa. However, in mouse the results differed from alligator and chick, and showed that 
both mandibular and palatal epithelial cell fate was determined by E12: when 
differentiated E12/E13 mandibular epithelium was cultured with the same age palatal 
mesenchyme, the mandibular epithelium maintained its original phenotype. Similarly, 
cultures of E12/E13 palatal epithelium recombined with mandibular mesenchyme kept 
their palatal phenotype. Intra- and interspecies palatal epithelium – palatal mesenchyme 
recombination cultures, where mesenchyme and epithelium were placed either parallel or 
perpendicular to their medial edges, demonstrated that the orientation of palatal 
mesenchyme directs the epithelial differentiation into nasal, oral, and MEE regions. Such 
epithelial-mesenchymal interactions are common to many developing organ, and for 
instance regulate the morphogenesis and cell differentiation of developing teeth: the early 
dental epithelium directs the tooth morphogenesis but during budding stage this role is 
shifted to dental mesenchyme (reviewed in Thesleff and Sharpe, 1997). 
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Growth factor signalling controls palate development 
Some of the molecular signalling pathways involved in the epithelial-
mesenchymal interactions have been unravelled recently. The importance of TGFβ 
signalling during palatogenesis was further emphasized in a study by Ito et al. (2003). The 
authors generated a cranial neural crest cell specific null allele of TGFβ receptor type II 
(TGFbr2) that can bind all Tgfβ ligands and also some Bmps, Tgfbr2fl/fl;Wnt1-Cre.  These 
animals exhibited cleft palate and calvarial abnormalities. This receptor is expressed both 
in the MEE cells and in the mesenchyme adjacent to MEE during secondary palate 
development. The cleft palate in the conditional Tgfbr2 mutants was shown to be due to 
about 10% decrease in cell proliferation in the CNC derived mesenchymal cell population 
in the palatal shelves from E14.5 onwards. Interestingly, in these mutants the palatal 
fusion was not disturbed; when palatal shelves were placed in organ culture they fused. 
Thus, in these mutants the epithelial function of Tgfβ3 may not be fully blocked, and 
there may be a cell autonomous requirement for Tgfβ signalling in the CNC derived 
palatal mesenchyme (Ito et al., 2003). Decreased cell proliferation in the Tgfbr2 mutants 
was correlated to reduced cyclin D1 expression in the mesenchyme of the palatal shelves 
in the mutant. The authors discuss that the altered expression of cyclin D1 is not likely to 
be the sole cause of the cleft palate phenotype since cyclin D1 null allele animals do not 
exhibit cleft palate (Fantl et la., 1995).  
The Tgfbr2 mutants showed 2.5 times elevated levels of Msx1 expression in the 
palatal mesenchyme. This finding seems contradictory to reports that Msx1 null-allele 
animals exhibit a cleft palate (Satokata and Maas, 1994). Cleft palate in Msx1-/- animals 
has been studied by Zhang et al. (2002). They demonstrated that the mesenchymal 
proliferation in the anterior palatal shelves is achieved by epithelial-mesenchymal 
interactions that combine Bone morphogenetic (Bmp) and Sonic hedgehog (Shh) 
signalling pathways, and that disruption of this signalling network leads to a cleft palate. 
In these mice, the primordial palatal shelves formed and elevated normally but failed to 
contact each other and did not fuse (Zhang et al., 2002). When Msx1-deficient palatal 
shelves were placed in contact with each other in organ culture, the shelves fused 
indicating that this was not the cause of the cleft palate. The cleft palate phenotype was 
rescued by crossing the Msx1-deficient mice with transgenic mice that overexpress human 
BMP4 under the control of Msx1 promoter. Furthermore, the authors showed that palatal 
mesenchyme expresses Bmp4, and that ectopic BMP4 protein induces expression of Shh 
in palatal epithelium. Ectopic Shh protein turns on the expression of Bmp2 in the 
mesenchyme, thus indicating that Shh signals from the epithelium back to the 
mesenchyme. Bmp2 then acts as a mitogen to stimulate proliferation in the mesenchyme. 
A similar signalling network has been established previously to tooth development (Chen 
et al., 1996; Bei et al., 2000; Dassule et al., 2000; Gritli-Linde et al., 2002). It is important 
to keep in mind that both Bmp2 and Bmp4 use the same receptors (BmprI and II in homo- 
and heterodimers) for their signalling. Interestingly, even though Msx1, Bmp2, Bmp4, and 
Shh were found to be expressed only in the anterior region of the palatal shelves (anterior 
to first molar tooth) at E12.5 and E13.5, posterior regions were also affected (Zhang et al., 
2002). Work from the Thesleff laboratory has shown that Shh is expressed along the 
entire anteroposterior axis of palatal epithelium at E13 (Keränen et al., 1999; Fig. 5d,g in 
Publication III), and that mesenchymal Fgf10 regulates epithelial expression of Shh 
through the epithelial receptor Fgfr2b (Fig. 5c in Publication III). It is possible that the 
expression of Shh is under complex regulation where Bmp signalling primarily regulates 
the anterior expression of Shh, and Fgf signalling along the whole anterior-posterior 
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length of the MEE. In the developing tooth it has been shown that Fgfs and Bmp4 induce 
both Msx1-independent and –dependent signalling pathways (Bei and Maas, 1998). 
 
Development of cranial base 
In the mammalian skull, the chondrocranium is made up of the cranial base 
together with the otic and nasal capsules (Fig. 2). The main function of the 
chondrocranium is to protect the brain, cranial nerves and sense organs. In addition, the 
growth of the cranial base is important to the growth of the middle third of the face 
(Meikle, 2002). 
 
 
 
 
Figure 2. Skeletal staining of cranial base in E17 mouse, caudal view. Mineralized bones 
are stained with alizarin red, and cartilages with alcian blue. Calvarium and mandibles 
have been removed. p, palatal shelves, ps, presphenoid, bs, basisphenoid, bo, basioccipital 
bone, #, intersphenoidal synchondrosis, *, spheno-occipital synchondrosis. The hyoid 
bone goes over the spheno-occipital synchondrosis; the centre of the hyoid bone is 
mineralized. 
 
 
Endochondral ossification in cranial base 
Cranial base bones form through endochondral ossification. Their development 
starts as cartilaginous condensations within the head mesenchyme. Condensation is a 
pivotal stage in skeletogenesis, and it is the main resource from which skeletal elements 
are built. Condensations have predictable sizes which affect whether skeletogenesis will 
be initiated, and what will be the final size and shape of the elements. In addition, genes 
specific to differentiation are upregulated at this stage (Hall and Miyake, 2000). There are 
three main condensations in the developing cranial base: (1) prechordal or trabecular 
condensation giving rise to the sphenoid bones, (2) parachordal condensation giving 
rise to the occipital bones, and (3) otic and nasal capsule condensation. These 
condensations differentiate into chondrocytes that will proliferate, and the prechordal and 
parachordal condensates will join and fuse to form a continuous plate of cartilage 
extending from the front of the skull to the foramen magnum to support the developing 
brain (Meikle, 2002). As chondrocytes mature they cease cell proliferation and become 
hypertrophic. The hypertrophic chondrocytes lay down calcified cartilaginous matrix. The 
mid-hypertrophic zone becomes vascularized. Blood vessels bring osteoclasts and 
osteoblasts into the cartilage. Osteoclasts will remove the cartilaginous matrix, and 
osteoblasts will replace it by bone (Mundlos and Olsen, 1997; Ornitz and Marie, 2002). 
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The joints between adjacent mineralized cranial base bones will stay cartilaginous, and 
are called synchondroses (Fig. 2). A synchondrosis has a resting zone of chondrocytes in 
the middle, which is surrounded by proliferative zones on both sides (Fig. 2 in Publication 
II). The proliferative zones are followed by hypertrophic zones, and finally erosive zones 
are found at both ends of the synchondrosis closest to the bone ends where hypertrophic 
chondrocytes are replaced by bone. Thus, synchondrosis can be regarded as two growth 
plates placed back to back, and consequently, growth at the synchondrosis is bidirectional 
(Meikle, 2002). Roberts and Blackwood (1984) performed a proliferation study and 
demonstrated that there is a caudorostral growth gradient in the cranial base cartilages; the 
highest growth rate being in the basioccipital and the lowest in the rostral edge of the 
presphenoid. 
The spheno-occipital synchondrosis is of special importance in humans since it 
remains open until the teenage years, unlike the other synchondroses which fuse early in 
life, and thus influences skull growth for a long period of time (Ingervall and Thilander, 
1972). For instance, maxillary hypoplasia in achondroplasia patients is caused by short 
cranial base, which is due to impaired growth at the spheno-occipital synchondrosis 
(Cohen et al., 1985). 
 
Molecular control of cranial base bone development 
The molecular mechanisms that regulate the development of cranial base are 
poorly studied. The occipital region normally expresses Hox genes from the paralogous 
groups 1 and 2 suggesting that they are at least partly patterned by Hox genes (Whiting, 
1997). Evidence towards the susceptibility of occipital and sphenoid bones to patterning 
by Hox genes has been given by transgenic mice misexpressing these genes. Ectopic 
expression of trunk level Hoxb7 (previously Hox-2.3) under chick β-actin promoter 
caused malformations in occipital bones and in basisphenoid (McLain et al., 1992). 
Ectopic expression of Hoxd4 (previously Hox-4.2) more rostrally than its normal 
mesodermal anterior boundary resulted in a homeotic transformation of the occipital 
bones towards a more posterior phenotype of neural arches, and in a partial or complete 
agenesis of the basisphenoid bone (Lufkin et al, 1992). Similarly, ectopic expression of 
Hoxb6 (previously Hox-2.2) in the head region led to missing or malformed occipital 
bones, basisphenoid, or squamosal (Kaur et al., 1992). 
In humans, missense, gain-of-function mutations in fibroblast growth factor 
receptor 3 (Fgfr3) result in chondrodysplasias many of which also affect the cranial base 
(Ornitz and Marie, 2002). A mouse model for human achondroplasia, which carries 
G369C mutation in Fgfr3, showed premature fusion of synchondroses (Chen et al., 1999). 
Similarly, transgenic mice carrying a heterozygous mutation S365C in Fgfr3, which is 
equivalent to a mutation causing thanatophoric dysplasia type I in humans, had 
prematurely fused and ossified synchondroses causing a short cranial base (Chen et al., 
2001). Mouse models harbouring K644E and K644M mutation reflecting the human 
thanatophoric dysplasia type II and severe achondroplasia with developmental delay and 
acanthosis nigricans (SADDAN), respectively, have been generated but only axial 
skeletons were studied (Iwata et al., 2000; Iwata et al., 2001). In both mouse models, the 
heterozygous mutants appear to have rounded heads (figure 2D in Iwata et al., 2000; 
figure 3D in Iwata et al., 2001), which is suggestive of cranial base malformations. All 
these mutant mice showed fewer proliferative chondrocytes in postnatal growth plates in 
limbs. This was caused by increased levels of Stat (signal transducer and activator of 
transcription) proteins. Stats activate cell cycle inhibitors, and thus prevent proliferation. 
Also, Indian hedgehog (Ihh) and parathyroid hormone related peptide (PTHrP) 
expression domains and intensities were reduced in growth plates indicating reduced 
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numbers of prehypertrophic chondrocytes, and thus impaired chondrocyte differentiation. 
Interestingly, Iwata et al. (2000) showed that K644E mutation in Fgfr3 increases 
proliferation of growth plate chondrocytes during embryonic chondrogenesis at E15. This 
coincided with a transient upregulation of patched (Ptc) expression, which is a receptor 
for Ihh. By E18 the proliferation rate and expression of Ptc were similar to wild type 
littermates. The expression pattern of Fgfr3, which is expressed in the proliferating 
chondrocytes, and Ihh, which is expressed in the neighbouring prehypertrophic cells, 
further supports the interaction between these two signalling pathways during embryonic 
development (Ornitz and Marie, 2002). Fgfr3 and Ihh are expressed in a similar pattern in 
spheno-occipital synchondrosis; Fgfr3c in prehypertrophic and proliferating cells, and Ihh 
in prehypertrophic and hypertrophic cell populations (Publication II). Thus, it is likely 
that Fgfr3 regulates the expression of Ihh also in the cranial base cartilages to keep 
chondrocytes immature and allow further growth. In long bones, Fgfr3 signalling through 
Stats is independent of Ihh (Chen et al., 2001). Whether Stats are involved in the growth 
of the synchondroses remains to be seen.  
Mice deficient in Fgfr2IIIc isoform showed reduced size of the bones of the 
cranial base, and premature fusion of the occipital and spheno-occipital synchondroses 
(wrongly termed ‘sutures’ in the publication) (Eswarakumar et al., 2002). Interestingly, 
these null allele mutants showed decreased expression of Ihh, PTHrP, and Runx2 
similarly to gain-of-function mutations in Fgfr3c. Thus, Fgfr2c appears to have an 
opposite role to Fgfr3c, and to be a positive regulator of ossification (Eswarakumar et al., 
2002). 
 
Development of calvarium 
Calvarial bones, which are composed mainly of two frontal, two parietal and an 
interparietal bone, form directly from mesenchyme by intramembranous ossification (Fig. 
3). Intramembranous ossification starts by mesenchymal cell condensation. Condensed 
mesenchymal cells undergo differentiation into osteoprogenitor cells which proliferate, 
and ultimately differentiate into osteoblasts that lay down bone matrix (Hall and Miyake, 
2000). Just as for chondrogenic condensations, osteogenic condensations affect the final 
size and shape of the bone, and are the sites where differentiation pathway commences. 
The mesenchymal condensations for calvarial bones form close to the cranial base and the 
brains. The calvarial bones grow as sheets between the brain and epidermis, and extend 
apically towards the top of the skull (Rice et al., 2000). Osteoblast differentiation occurs 
at the bone margins, or osteogenic fronts, where osteoblasts invade into and progenitor 
cells are recruited from the surrounding mesenchyme. Prior to birth, calvarial bones 
approximate each other with sutures forming between the osteogenic fronts. Sutures are 
fibrous joints that accommodate brain growth. In mouse all calvarial sutures, except the 
posterior section of the frontal suture, remain patent. In humans metopic/frontal suture is 
obliterated by the third year, and others fuse in the third or fourth decade of life (Meikle, 
2002). 
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Figure 3. Calvarial bone development in mouse. Skeletal stain by alizarin red 
(mineralized bones) and alcian blue (cartilages) in calvarial explants. Calvarial bones start 
developing from osteogenic condensations at E12-E13. Mineralized frontal (f) and 
parietal (p) bones are visible by E13.5. By E14 the interparietal (ip) bone is visible as two 
separate ossification centres. These lateral ossification centres grow medially to form the 
interparietal bone. By E15 the sagittal suture (s) between the opposing parietal bone plates 
has formed, as have the coronal sutures (arrows) between the frontal and parietal bone 
plates. e, eye. Images are the same magnification. 
 
 
Tissue interactions during calvarial suture formation 
Calvarial bones grow in close contact with dura mater which is the outermost 
layer of the meninges covering the brain. Interactions between the dural cells and 
calvarial mesenchyme have been shown to be important in the regulation of osteogenesis 
within a suture, and thus in the suture fate (i.e. patent or ossified). Opperman et al. (1993) 
performed in vitro organ cultures of E19 and postnatal day 1 (P1) rat calvaria with or 
without the underlying dura mater. This study answered some fundamental questions 
about calvarial growth and suture formation. The authors demonstrated that calvarial bone 
growth was not influenced by biomechanical forces originating from the cranial base as 
bone growth was not affected in culture where there were no mechanical tensions; they 
showed that tissue interactions between the calvarial mesenchyme and the dura mater 
were required to maintain coronal sutures patent as these sutures were obliterated by bone 
in cultures without dura mater, and that foetal dura mater was not required for initial 
suture formation. Opperman et al. (1995) continued their studies by showing that in 
E19/P1 rat calvarial cultures dura mater maintains patent sutures by soluble factors since 
separation of mesenchyme and dura mater by a polycarbonate filter kept the coronal 
sutures patent. Further evidence for the requirement of dura mater in the suture fate was 
published on posterior frontal (PF) suture on postnatal rats (Roth et al., 1996). These 
authors performed operations on P8 rats to separate dura mater from the PF suture by a 
silicone sheet, and studied the effect at the start (P15), during (P20), and after (P30) 
fusion. When dura mater was separated from the PF suture by a silicone sheet, the PF 
suture ossification was delayed. Bradley et al. (1997) and Levine et al. (1998) studied 
whether the dura mater underneath the suture specifies the suture patency. They showed 
that 180º rotation and translocation of murine sagittal suture onto the PF dura mater 
caused the normally patent sagittal suture to fuse and ossify. The PF suture, which now 
overlaid sagittal dura mater, stayed patent. The sagittal suture, which overlaid the PF dura 
mater, fused. Thus, these authors demonstrated that there are regional differences in the 
dura mater in adult animals. Opperman et al. (1998) showed that the function of the dura 
mater in the suture fusion involves induction of cell proliferation prior to fusion which is 
followed by increased collagen synthesis in fusing sutures. At the same time, work from 
the Thesleff laboratory demonstrated that a similar mechanism regulates the suture fate 
already during embryogenesis (Kim et al., 1998). This study showed that E16 mouse 
sagittal suture without dura mater fused within 72 hours in culture while control explants 
still had patent sagittal sutures. Thus, there is ample evidence from many laboratories that 
paracrine cell signalling mechanisms between the dura mater and overlying suture 
mesenchyme modulate suture ossification throughout the development. 
 
Regulation of calvarial suture fate by growth factor signalling 
The first publication that identified some of the soluble factors signalling from the 
dura mater to the suture was by Opperman et al. (1997) where the authors localized 
18 
Tgfβ isoforms 1-3 to frontal and coronal sutures in postnatal rats by 
immunohistochemical analysis, and importantly showed that Tgfβ3 levels increased in the 
patent coronal sutures when PF suture was fusing. To better understand the role of 
different Tgfβ isoforms in the suture fate, Opperman et al. (1999) performed in vitro 
calvarial cultures in the presence or absence of neutralizing antibodies against the 
isoforms. Control coronal sutures did not fuse when the function of Tgfβ1 or β2 was 
blocked, but fused when the function of Tgfβ3 was blocked. Coronal sutures cultured in 
the absence of the dura mater were rescued from fusion by blocking the function of Tgfβ2 
but not Tgfβ1 or β3. These studies demonstrated that Tgfβ isoforms play differential roles 
in the regulation of suture fate so that isoform β2 plays a role in the suture fusion while 
β3 is needed to keep sutures patent. Further support for these findings came from a recent 
study where injection of Tgfβ3 into the PF suture prior to fusion delayed the fusion 
(Opperman et al., 2002). This study also demonstrated that in Tgfβ3-treated PF sutures 
the levels of Tgfβ2 and transforming growth factor beta receptor type I (TβR-I) were 
downregulated. Tgfβ isoforms were shown to control the number of cells; Tgfβ2 
increased cell proliferation while Tgfβ3 reduced it (Opperman et al., 2000). Also, this 
study showed that patent suture has higher numbers of apoptotic cells than fusing one. 
This finding is in accordance with Rice et al. (1999) where apoptotic cells were found in 
calvarial bones, intervening sutures and fontanelles from E16 onwards. Thus, cell 
confluency plays a role in the regulation of suture fate. Most et al. (1998) and Mehrara et 
al. (1999) showed that increased levels of Tgfβ1 and Fgf2 proteins were produced in the 
dura mater underlying the PF suture just prior and during the fusion while patent sagittal 
suture produced only low levels of these growth factors during the same time period. 
Greenwald et al. (2001) targeted an adenoviral construct of secreted form of Fgf2 to PF or 
coronal dura mater in utero to demonstrate that Fgf2 was responsible for the increased 
proliferation, extracellular matrix molecule synthesis, and for the synthesis of Tgfβ1. 
They also showed that a similar targeting of a truncated form of Fgfr1, which blocks Fgf 
signalling, caused the infected PF sutures to stay patent. Thus, this elegant study showed 
that Fgf signalling regulates postnatal suture fate. The role of Fgf signalling in the 
regulation of suture patency had previously been shown in embryonic mouse tissue (Kim 
et al., 1998). This study demonstrated that recombinant human FGF4 soaked beads, which 
were placed on osteogenic fronts of parietal bones of E16 calvarial explants, accelerated 
sagittal suture fusion by increasing the amount of proliferative cells. Interestingly, FGF4-
containing beads placed in the mid-sutural mesenchyme did not alter suture patency. Kim 
et al. (1998) further demonstrated that Bmp signalling does not regulate embryonic suture 
patency since BMP4-containing beads placed either on osteogenic fronts or in the mid-
sutural mesenchyme of sagittal suture did not alter the patency of the sagittal suture but 
increased sutural tissue thickness. 
Some of the target molecules and functions of Fgf and Bmp signalling that control 
the osteogenesis in the developing suture have been discovered. In the sagittal suture, Fgf 
signalling has been shown to induce the expression of transcription factors Msx1 (but not 
Msx2) and Twist, and the extracellular matrix protein bone sialoprotein (Bsp) in the suture 
mesenchyme, and Bmp signalling has been shown to upregulate the expression of 
transcription factors Msx1, Msx2, and Inhibitors of differentiation (Id) (Kim et al., 1998; 
Rice et al., 2000). Twist was shown to be both an upstream regulator and a downstream 
target of Fgf signalling; not only did exogenous FGF2 induce the expression of Twist, but 
lack of Twist also caused Fgfr2 protein to be misexpressed in the sagittal suture (Rice et 
al., 2000). Work from the Morriss-Kay laboratory has shown that FGF2 beads upregulate 
the expression of osteopontin (Op) and Fgfr1 at high concentrations and Fgfr2 at low 
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concentrations in coronal sutures (Iseki et al., 1997; Iseki et al., 1999). The authors 
concluded that a concentration gradient of Fgf ligand modulates the differential 
expression of Fgfr1 and -2, and that these receptors have differential roles so that 
signalling through Fgfr2 is responsible for the proliferation of osteogenic cells, and 
signalling through Fgfr1 regulates osteogenic differentiation. Kim et al. (1998) showed 
that FGF2-containing beads induced cell proliferation in the sagittal suture. 
Many Fgf ligands are expressed broadly by suture mesenchyme and the 
underlying dura mater both in embryonic and postnatal tissues (Iseki et al., 1997; Kim et 
al., 1998; Rice et al., 2000; Hajihosseini and Heath, 2002) while Bmp2 and Bmp4 show 
restricted expression pattern to osteogenic fronts and to dura mater (Kim et al., 1998). Fgf 
receptors show a specific spatiotemporal expression pattern in the developing sutures. 
Fgfr1, 2, and 3 are expressed in coronal sutures (Iseki et al., 1999). Fgfr1c, Fgfr2b and -
2c, and Fgfr3c are expressed by the osteogenic fronts and to a lesser degree in the suture 
mesenchyme in sagittal (Kim et al., 1998; Rice et al., 2000) and in lambdoidal sutures 
(Fig. 6 in Publication II). Kim et al. (1998) and Rice et al. (2000) further showed that the 
same localization of Fgfr transcripts continues on postnatal tissues. These expression 
patterns together with the results from the bead assays support the role of Fgf signalling in 
the regulation of the proliferative osteogenic cell population. 
The molecules downstream of Fgf and Bmp signalling also show restricted 
expression patterns during suture development. Msx1 and Msx2 are expressed in a very 
similar pattern in suture mesenchyme and in osteogenic fronts from E15 onwards (Kim et 
al., 1998). After birth the expression of Msx genes is downregulated so that by P5 the 
expression of Msx2 has disappeared while Msx1 is still expressed in a very low level. Bsp 
is expressed throughout the calvarial bones during embryogenesis, and in postnatal tissues 
the expression of Bsp is stronger in osteogenic fronts (Rice et al., 2000). Twist is 
expressed by suture mesenchyme and osteogenic fronts, and Id expression is localized to 
suture mesenchyme. Both Twist and Id expression decreased with increasing maturity of 
osteogenic cells (Rice et al., 2000). Thus, the functional assays together with the 
expression pattern analysis indicate that Bmp signalling regulates mostly proliferative 
(Msx1+, Msx2+, Id+) osteoblast cell populations in the developing sutures while Fgf 
signalling can regulate both proliferative osteoblastic cells (Msx1+, Twist+) and mature 
(Op+, Bsp+) osteoblast cell populations. 
These two growth factor signalling pathways can either be linked, or they can use 
parallel pathways. Both pathways can regulate the expression of Msx1. Also, Id can link 
the pathways as its expression is regulated by Bmps, and it can suppress the expression of 
Twist, which is involved in Fgf signalling (Pesce and Benezra, 1993; Rice et al., 2000). 
More evidence to support the idea that Fgf and Bmp signalling pathways are linked 
during osteogenesis was given by Warren et al. (2003) who showed that Bmp antagonist 
noggin was expressed in suture mesenchyme and dura mater in patent coronal and sagittal 
sutures but not in fusing PF suture. The authors showed that in the PF suture noggin 
expression was suppressed by Fgf2 prior to suture fusion. The expression of noggin was 
regulated in a suture-specific manner since Fgf2 was present only in the dura mater of the 
fusing PF suture (Warren et al., 2003). It seems that Fgf2 regulates the activity of Bmp 
signalling through noggin so that when the time is right Fgf signalling will suppress 
noggin, and allow more Bmp activity, which will then commence osteoblastic 
differentiation in fusing sutures. A complementary in vitro study on primary murine bone 
cell cultures showed that Fgf2 and noggin both inhibit differentiation of osteoblastic cells 
in a stage specific manner (Kalajzic et al., 2003). This study demonstrated that treatment 
of osteoblastic cell cultures with Fgf2 protein prevented the cells to express early markers 
of osteoblasts such as type I and III collagen while treatment with noggin protein blocked 
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the expression of later markers of Bsp and osteocalcin (Oc). In other words, Fgf2 kept the 
osteoblastic cells at progenitor stage, while noggin inhibited further differentiation into 
mature osteoblasts. 
 
Molecular control of osteogenesis during calvarial development 
The studies discussed above relied on the wild type animals. The understanding of 
molecular mechanisms involved in calvarial bone development has also increased 
considerably through analysis of mouse mutants that show ossification abnormalities in 
the skull (Table II). Mice deficient for the Runt-domain containing transcription factor 
Runx2 (previously Cbfa1) lacked all bones including those of the skull vault (Otto et al., 
1997). Runx2 was shown to be necessary for osteoblast differentiation, and to act as an 
activator of osteoblast-specific gene expression. The transcription factor Msx2 has been 
suggested to be an upstream regulator of Runx2 in osteoprogenitor cells since Runx2 
expression is down-regulated in Msx2-deficient mice (Satokata et al., 2000). Msx2-
deficient mice exhibited a delay in calvarial bone ossification and an overall decrease in 
bone volume. Overexpression of Msx2 on the other hand caused overgrowth of parietal 
bones, and increased the amount of proliferative cells in the osteogenic fronts (Liu et al., 
1999). Calvarial abnormalities are also found in Msx1 null allele mice which exhibit 
overlapping parietal bones, and enlarged anterior fontanel (Satokata and Maas, 1994), and 
calvarial phenotype of Msx2 mutant is enhanced by genetic combination with Msx1 loss 
of function (Satokata et al., 2000). Thus, Msx proteins have a pivotal role in mediating the 
balance between early osteoprogenitor cell proliferation and differentiation in calvarial 
development. In humans, haploinsufficiency of Msx2 results in parietal foramina which is 
a skull ossification defect in parietal bones (Wilkie et al., 2000; Wuyts et al., 2000a), 
whereas enhanced Msx2 gene function causes premature suture fusion resulting in Boston 
type craniosynostosis (Jabs et al., 1993; Ma et al., 1996). Parietal foramina can also be 
caused by mutations in the paired-type homeobox gene ALX4 (Wu et al., 2000; Wuyts et 
al., 2000b; Mavrogiannis et al., 2001). Mice lacking Alx4 exhibit a calvarial bone 
phenotype similar to that of Msx2 mutants; ossification is delayed and parietal bones do 
not extend over the superior aspect of the skull in newborns (Qu et al., 1997). In humans, 
heterozygous loss of Twist causes Saethre-Chotzen craniosynostosis, and in a subset of 
the affected individuals it can cause parietal foramina (Thompson et al., 1984). In cultured 
human mutant calvarial osteoblasts from Saethre-Chotzen patients, the reduced Twist 
dosage increased cell growth, collagen synthesis and matrix production, inhibited 
expression of Runx2 and Oc, and induced apoptosis (Yousfi et al., 2001, 2002a, 2002b). 
Mice heterozygous to Twist have been proposed as a model of the human disease as they 
exhibit fusions of coronal sutures (Carver et al., 2002). A recent study from the Maxson 
laboratory demonstrated that Msx2 and Twist function in parallel to control the 
proliferation and differentiation of early osteoblast cell populations in frontal bone 
primordia, and that the growth and patterning of the frontal bone requires cooperative 
contributions from both Bmp and Fgf pathways (Ishii et al., 2003). Mice lacking a 
forkhead/winged helix transcription factor Foxc1 develop only rudimentary calvarial 
bones and also show other skeletal abnormalities (Grüneberg, 1943; Kume et al., 1998; 
Hong et al., 1999). Heterozygous Foxc1 mutants have delayed ossification of skull bones 
(Fig. 3h in Publication I). Thus, it seems that a proper dosage of many transcription 
factors is essential for regulating osteogenesis during calvarial development. 
Gain-of-function mutations of Fgfrs lead to chondrodysplasia due to impaired 
chondrocyte proliferation and differentiation. At sutures, which are osteogenic, gain-of-
function mutations in Fgfrs lead to premature fusion of some or all sutures (Ornitz and 
Marie, 2002). Of human craniosynostosis syndromes caused by mutations in FGFRs only 
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Crouzon syndrome has no associated limb abnormalities (Carlton et al., 1998). Mice 
carrying a Pro250Arg mutation in Fgfr1, which is the most commonly found mutation in 
Pfeiffer syndrome (acrocephalosyndactyly) patients, have synostosed frontal, sagittal, and 
coronal sutures (Zhou et al., 2000). These animals exhibited accelerated bone formation in 
calvarial sutures which was manifested by increased expression of Runx2, Op, Oc, and 
Bsp in calvarial sutures, and by both increased proliferation and differentiation of 
osteoblastic cells. Interestingly, no differences were noted in growth plates of mutant and 
wild type animals; neither were cranial base synchondroses affected making the 
Pro250Arg mutation in Fgfr1 to be osteoblast cell lineage specific. To support the role of 
Fgfr1 in the control of calvarial suture ossification, adenoviral expression of dominant-
negative form of Fgfr1 was shown to inhibit calvarial suture fusion (Greenwald et al., 
2001). When Fgfr2c hemizygote mice were produced the phenotype of the mutant 
animals resembled that of Apert/Pfeiffer patients (Hajihosseini et al., 2001). This would 
seem contradictory since these patients have gain-of-function mutations in FGFR2b or in 
FGFR2c. The authors demonstrated that the heterozygotic deletion of exon 9, which is 
specific to the Fgfr2c isoform, caused a splicing switch that resulted in ectopic Fgfr2b 
expression. The authors also showed that Fgf10, which is one of the ligands that can 
activate Fgfr2b, is present in coronal sutures, and ectopic signalling is possible. This 
misexpression of Fgfr2b thus caused the excessive ossification in coronal sutures. Revest 
et al. (2001) showed that mice deficient for Fgfr2b (and unaffected expression of Fgfr2c) 
exhibited a delay in intramembranous ossification and a reduction in skull bone mass. 
Mice lacking both alleles of Fgfr2c without splice switching also demonstrated delayed 
ossification of skull bone plates that was caused by decreased cell proliferation at coronal 
suture from E16.5 onwards (Eswarakumar et al., 2002). Thus, both isoforms of Fgfr2 
appear to function as positive regulators of ossification during calvarial development. 
Mansukhani et al. (2000) demonstrated that when OB1 cell line, which is a proliferative 
mouse osteoblastic cell line capable of differentiating into nodule-forming mature 
osteoblasts, was retrovirally transfected to overexpress Fgfr2 carrying activating Apert 
(Ser252Trp) or Crouzon (Cys342Tyr) mutations, the cells exhibited increased 
proliferation, and suppressed differentiation into nodule-forming mature osteoblasts. 
Of Fgf ligands, Fgf2, 3, 4, and 18 have been shown to be involved in regulating 
calvarial suture ossification. Transgenic mice overexpressing Fgf2 show increased 
apoptosis in the osteogenic fronts of the posterior frontal suture (Mansukhani et al., 2000). 
Fgf2-treated posterior frontal sutures cultured in vitro show induced cell proliferation and 
enhanced suture fusion (Moursi et al., 2002). In chicks, blocking endogenous Fgf2 
activity in calvarial bones caused inhibition of proliferation and osteoblastic 
differentiation in a dose-dependent manner (Moore et al., 2002). Heterozygous Bulgy-eye 
(Bey) mice, which were produced by retroviral insertional mutagenesis, led to the finding 
that overexpression of both Fgf3 and Fgf4 in calvarial sutures caused them to fuse 
prematurely (Carlton et al., 1998). Ectopic adenoviral expression of Fgf2 in coronal 
sutures also caused premature fusion (Greenwald et al., 2001). Two publications 
demonstrated at the same time that Fgf18 is required for both osteogenesis and 
chondrogenesis. Ohbayashi et al. (2002) and Liu et al. (2002) showed that Fgf18-/- mice 
exhibited delayed calvarial ossification and suture closure due to decreased proliferation 
of osteogenic cells, and delayed terminal differentiation of osteoblasts. In the skull vault, 
the expression of Runx2 and Op were decreased in the mutant animals. Fgf18 appears to 
control the maturation of osteoblasts from Runx2-positive, Op-negative, and Oc-negative 
cells to Runx2-, Op-, and Oc-positive cells (Ohbayashi et al., 2002). In chondrogenesis, 
the role of Fgf18 appeared to be the opposite of osteogenesis. In Fgf18 null allele mice the 
growth plates were enlarged, and more cells were undergoing proliferation and 
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differentiation (Ohbayashi et al., 2002; Liu et al., 2002). The authors concluded that 
Fgf18 is a positive regulator of osteogenesis but a negative regulator of chondrogenesis. 
Both groups suggested that the differential role in chondro- and osteogenesis may be 
based on a differential receptor usage; Fgf18 could use Fgfr3c in chondrocytes and Fgfr2c 
in osteoblasts (Ohbayashi et al., 2002; Liu et al., 2002). In cell culture it has been shown 
that Fgf18 may compensate for the action of Fgf2 in proliferation, differentiation and 
matrix synthesis in bone and cartilage (Shimoaka et al., 2002). This study also 
demonstrated that Fgf10 had no effect on osteoblasts or chondrocytes in cell culture. 
Interestingly, expression pattern analysis has shown that Fgf10 is expressed in coronal 
sutures (Hajihosseini et al., 2001). 
Roles of Bmp and Fgf signalling in human calvarial osteoblast cells have been 
shown to be similar to murine models. Human studies have focused on materials obtained 
from craniosynostosis patients, and to human neonate calvarial osteoblastic cell cultures. 
Calvarial cells cultured from Apert patients have demonstrated that these mutant cells 
show increased levels of alkaline phosphatase (Alp) and type I collagen expression (Col 
I), and increased matrix formation which indicate increased osteogenesis in mutant cells 
(Lomri et al., 1998). These cells also show reduced levels of Fgfr2 protein but unaltered 
levels of mRNA (Lemonnier et al., 2000). Coronal sutures of Apert patients also show 
increased levels of Col I, Op and Oc proteins, and reduced levels of Fgfr2 (Lemonnier et 
al., 2000). The function of Fgf signalling in human calvarial osteoblasts is similar to 
murine models: Fgf signalling has a dual role so that it promotes proliferation of 
preosteoblasts and prevents their maturation while in mature osteoblast cells it promotes 
differentiation and matrix mineralization (Debiais et al., 1998). The increased 
osteogenesis by activating Fgfr mutations, such as found in Apert syndrome, has been 
linked to increased levels of N-Cadherin and cell-cell adhesion (Debiais et al., 2001; 
Lemonnier et al., 2001b). Lemonnier et al. (2001a) have also shown that mature 
osteoblasts and osteocytes in Apert coronal sutures show increased levels of apoptosis 
through activation of protein kinase C (PKC)-pathway leading to activation of caspase-8. 
Also Bmp signalling has been shown to regulate osteoblast differentiation and apoptosis 
in human calvarial osteoblasts: it induces transient N-Cadherin expression which is 
required for the expression of osteoblast specific genes such as Runx2 and Oc (Haÿ et al., 
2000), and it actives apoptosis via Smad-independent, PKC-dependent pathway similarly 
to Fgf signalling (Haÿ et al., 2003). These authors showed further evidence that Bmp-
induced apoptosis is mediated through bone morphogenetic factor receptor type Ib 
(BmprIb) in osteoblasts, and that this occurs independently of Bmp-induced 
differentiation of osteoblasts. 
 
Table II. Mouse mutants with calvarial phenotype. 
 
Mouse mutant Calvarial phenotype Defect Molecular 
mechanism
References
Transcription factor     
Alx3-/-;Alx4-/- Reduced frontal and 
parietal bones 
Increased apoptosis in 
frontonasal mass,
 Beverdam et al., 2001
Alx4-/- Calvarial foramen Delayed ossification of 
parietal bones
 Qu et al., 1997
Alx4-/-;Cart1-/- Absence of skull 
bones 
  Qu et al., 1999
Cart1-/- Absence of skull 
bones 
  Zhao et al., 1996
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Foxc1-/- and 
Congenital 
hydrocephalus 
(Foxc1) mutant 
Rudimentary calvarial 
bones 
Reduced proliferation 
of osteoblastic cells
Misexpression of 
Msx2 and Alx4 in 
calvarial mesenchyme
Gruneberg, 1943; 
Kume et al., 1998; 
Publication I
Extra toes (Gli3) 
mutant 
Open skull vault   Johnson 1967; Mo et 
al., 1997
Gli2-/- Open skull vault Delayed ossification  Mo et al., 1997
Hic1-/- Absent skull bones   Carter et al., 2000
Msx1-/- Enlarged anterior 
fontanelle 
Delayed ossification, 
reduced proliferation
 Satokata and Maas, 
1994
Msx1-/-;Msx2-/- Loss of membrane 
bones 
Delayed ossification, 
reduced proliferation
 Satokata et al., 2000
Msx2-/- Calvarial foramen Delayed ossification, 
reduced proliferation
 Satokata et al., 2000
Msx2-/-;Twist+/- Calvarial foramen Delaye ossification, 
reduced proliferation
 Ishii et al., 2003
Runx2-/- Absence of bones Osteoprogenitor cell 
development arrested
 Komori et al., 1997
Ski-/- Absent skull bones Increased apopotosis 
in craniofacial 
mesenchyme
 Berk et al., 1997
Twist+/- Calvarial foramen Delayed ossification, 
reduced proliferation
 Ishii et al., 2003
Growth factors and 
receptors 
    
Bulgy-eye (Bey) 
mutant 
Synostosis of several 
cranial sutures 
 Overexpression of 
Fgf3 and Fgf4
Carlton et al., 1998
Fgf18-/- Delayed calvarial 
ossificiation 
Transient reduction of 
osteogenic 
proliferation at E14.5, 
and delay of terminal 
differentiation of 
osteoblasts
 Ohbayashi et al., 2002
Fgfr1 Pro250Arg 
mutant 
Synostosis of several 
cranial sutures 
Increased proliferation 
and differentiation of 
osteoblasts
Increased expression 
of Cbfa1
Zhou et al., 2000
FgfR2-IIIc hemizygote Coronal synostosis  Splicing switch to 
ectopic expression of 
FgfR2-IIIb
Hajihosseini et al., 
2001
Shh-/- Absent of hypoplastic 
craniofacial bones 
Midline failure, 
decreased cell survival 
and proliferation
 Chiang et al., 1996
TGFb2-/- Small and dysmorphic 
calvarial bones 
  Sanford et al., 1997
Gap junction molecule     
Connexin 43-/- Hypoplastic cranial 
bones 
Delayed ossification  Lecanda et al., 2000
Extracellular matrix 
molecule 
    
Perlecan (Hspg2)-/- Dilated sutures at 
midline 
Reduced ossification Disorganized collagen 
fibrils and 
glycosamino-glycans
Arikawa-Hirasawa et 
al., 1999
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AIMS 
 
The main aim was to study how growth factor signalling regulates the development of 
craniofacial structures, in particular the formation of calvarial bones and secondary palate. 
 
I What are the molecular mechanisms that control the progression of calvarial bone 
growth from the initial sites of bone formation? Specifically, does Foxc1 regulate 
osteogenic cell proliferation in the calvarial mesenchyme? What growth factor 
signalling pathway does Foxc1 regulate in calvarial mesenchyme, and what are the 
downstream targets? 
 
II What are the molecular mechanisms that control the growth of cranial base 
synchondroses during embryonic development? Specifically, are fibroblast growth 
factor receptor (Fgfr) isoforms expressed in synchondroses? In which cell 
populations are the Fgfr isoforms expressed, and what do the expression patterns 
tell about their possible functions in synchondroses? 
 
III What are the molecular mechanisms that control the formation of secondary 
palate? Specifically, does reiterative Fgf10/Fgfr2b signalling play a role in the 
development and outgrowth of a palatal shelf bud? Is Fgf10/Fgfr2b signalling 
needed for the proliferation of cells in the early palatal shelf? What are the 
epithelial downstream target(s) of Fgf10/Fgfr2b signalling, and do they signal 
back to the mesenchyme? 
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MATERIALS AND METHODS 
 
Mating and genotyping 
Mouse embryos were obtained by mating NMRI mice (Jackson Laboratories, USA); 
Fgfr2b null allele embryos were obtained from mating heterozygous Fgfr2b mice (De 
Moerlooze et al., 2000); Foxc1 mutant embryos were obtained from mating heterozygous 
congenital hydrocephalus (ch) mice (Jackson Laboratories, USA). The vaginal plug date 
was designated as E0. Mice carrying a Fgf10 null allele (Min et al., 1998) were kindly 
provided by Dr. Clive Dickson’s laboratory, Cancer Research, UK. K-14Cre;Shhc/n 
(Dassule et al., 2000) and K-14Cre;Smoc/n (Gritli-Linde et al., 2002) were from Dr. Amel 
Gritli-Linde, Göteborg University, Sweden. 
Fgfr2b null allele mice were genotyped by PCR as described previously (De 
Moerlooze et al., 2000). In ch mice, a nonsense point mutation in the amino terminus of 
the DNA binding domain of Foxc1 gene creates an early stop codon, and a non-functional 
Foxc1 protein (Kume et al., 1998; Hong et al., 1999). 
To detect the C?T substitution in the Foxc1 gene in ch mice solid-phase 
minisequencing was set up. A fragment of Foxc1 sequence surrounding the variable 
nucleotide in Foxc1 gene was amplified from tail DNA samples by PCR. We used GC-
rich PCR system kit (Roche) according to the manufacturer’s protocol with the exception 
of using 10 pmol of 5’-biotin-labeled reverse primer. Forward primer 5’-
CTACCAGTTCATCATGGACCGC-3’ and 5’-biotinylated reverse primer 5’-
7CGAGCGTCCAGTAGCTGCCC-3’ were used (7=methylation). PCR cycle: 95°C for 3 
minutes, 63°C for 1 minute, 72°C for 1 minute, and 95°C 1 minute. Cycle was repeated 
33 times, and the final products were extended at 72°C for 8 minutes. The PCR products 
were used as a template for solid-phase minisequencing as described in Suomalainen and 
Syvänen (1996); detection primer 5’-GGGACAATAAGCAGGGCTGG-3’, 3H-labelled 
dCTP (53.0 Ci/mmol specific activity, Amersham), and 3H-labelled TTP (118 Ci/mmol 
specific activity, Amersham) were used. Radiolabelled dCTP was incorporated onto the 
detection primer bound to the wild type allele of Foxc1, and radiolabelled TTP to the 
mutated allele. The amount of radiolabel was measured in a scintillation counter (Wallac) 
using 3H counting program. Counting the ratio of 3H-dCTP and 3H-TTP between 
duplicate samples indicated the nucleotide present at the variable site of the Foxc1 gene. 
If the 3H-dCTP/3H-TTP ratio was >10, the genotype was wild type. A ratio between 0.5-2 
corresponded to a heterozygous, and a ratio <0.1 corresponded to a mutant genotype. 
 
Tissue dissection and culture 
Calvarial explants: E15 calvaria were dissected from heads. Brains and epithelia were 
removed. After brain removal, the dura mater was still attached to the mesenchyme of the 
explant. Explants were cultured on Nuclepore polycarbonate filters, supported by grids, in 
Dulbecco’s minimal essential medium (DMEM). DMEM was supplemented with 
GlutaMAX-1 (Life Technologies), 10% fetal calf serum (FCS), 100 µg/ml of ascorbic 
acid, and 20 IU/ml penicillin-streptomycin. Explants were cultured at 37°C in 5% CO2 for 
48 hours. 
Palatal explants: E12.5 and E13.5 palatal shelf primordia were dissected from maxillary 
tissue and cultured adjacent to each other in DMEM supplemented as described. Palatal 
explants were cultured 24 - 48 hours. 
 
Bead implantation assays 
Affi-Gel blue agarose beads (100-200 µm, Bio-Rad) were incubated with 100 ng/µl 
recombinant human BMP2 (R&D Systems) for 1 hour at 37°C. Heparin coated acrylic 
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beads (Sigma) were used for recombinant human FGF2 or FGF10 (50 ng/µl, R&D 
Systems). Control beads were soaked with the same concentration of bovine serum 
albumin under the same conditions. Protein-containing beads were placed on the top of 
the calvarial explants under a dissecting microscope. Explants were cultured as described 
above, and fixed in 4% paraformaldehyde (PFA) overnight at 4°C. 
 
Skeletal staining 
E17 calvaria or E15 calvarial explants cultured for 7 days were fixed in 95% ethanol 
overnight, and stained in alcian blue staining solution (150 µg/ml alcian blue, 80% 
ethanol, and 20% acetic acid) overnight. Excess alcian blue was removed in 95% ethanol. 
Tissues were cleared in 2% KOH for 2 hours before transfer into the alizarin red staining 
solution (75 µg/ml of alizarin red in 1% KOH) and incubated 4-15 hours. Explants were 
cleared in 20% ethanol/1% KOH, and transferred into glycerol-ethanol (1:1) solution, and 
stored at 4°C. The shortest distance between the parietal bone margins was measured as 
the minimum sagittal suture width. Statistical analysis of the mean values was performed 
by t-test. 
 
BrdU incorporation and TUNEL analysis 
Calvaria: Pregnant ch heterozygote females were injected intraperitoneally (i.p.) with 2 
ml/100 g body weight of undiluted 5-bromo-2’-deoxyuridine (BrdU) solution (Zymed) for 
E13 and E15 embryos. After 2 hours, embryos were collected, fixed in 4% PFA, and 
paraffin embedded. BrdU incorporation was immunodetected using BrdU staining kit 
(Zymed). BrdU-positive cells were counted in the calvarial mesenchyme adjacent to the 
advancing osteogenic condensations which were detected morphologically. A minimum 
of 10 sections per mouse were analyzed. The same size area of the calvarial mesenchyme 
was marked on each section. Two independent observers performed cell counting. 
Statistical analysis on average cell counts was performed by t-test. Terminal 
deoxynucleotidyl transferase-mediated dUTP nick-end labelling (TUNEL) assay was 
performed using DeadEnd Colorimetric TUNEL System (Promega). 
Palates: Mice were injected i.p. with 1ml/100 g body weight BrdU and sacrificed after 2 
hours to collect E12 and E13 embryos. In palatal shelf explants in culture, the cell 
proliferation was assessed also by BrdU incorporation. Explants from E13 embryos were 
cultured 20 hours, and then BrdU pulsed for 4 hours (1:200 BrdU in culture medium). 
Embryos and palate explants were then treated as above for immunodetection of BrdU-
positive cells, which were counted by 2 individuals. 
 
35S in situ hybridization 
In situ hybridization on tissue sections was performed as described by Vainio et al. 
(1993). Briefly, paraffin sections were cleared from paraffin by xylene and rehydrated in 
ethanol series. Tissue sections were then permeabilized with proteinase K treatment, and 
hybridized overnight at 52 ºC with 35S-UTP labelled riboprobes. After hybridization 
unspecifically bound and excess probe was removed by washes and RNase A treatment, 
dehydrated in ethanol series, and coated with autoradiography emulsion. Slides were 
exposed for 14 days, developed, fixed, counterstained with haematoxylin, dehydrated, and 
mounted with xylene-based DePex (BDH). The preparation of the following RNA probes 
has been described: Alx4 (Hudson et al., 1998), Bsp (Rice et al., 1999), Fgf3, Fgf7, Fgf10 
(Kettunen et al., 1998; Kettunen et al., 2000), Fgfr1b, Fgfr1c, Fgfr2b, Fgfr2c (Rice et al., 
2000), Foxc1 (Hiemisch et al., 1998b), Foxc2 (a kind gift from Dr. Kirsi Sainio), Msx1 
and Msx2 (Jowett et al., 1993), osteopontin (a kind gift from Dr. Marian Young), Shh 
(Vaahtokari et al., 1996). Both bright and dark field images were taken from hybridized 
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sections. Silver grains were selected from the dark field image, coloured red, and 
superimposed onto the identical bright field image. 
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RESULTS AND DISCUSSION 
 
Molecular biology of Foxc1 during calvarial development (Publication I) 
The calvarial bones develop through intramembranous ossification so that first an 
osteogenic condensation must form followed by bone growth from the condensate 
towards the apex of the skull. To study what regulates and maintains this outgrowth and 
development of calvarial bones from the condensates, we studied congenital 
hydrocephalus (ch) mutants that develop only rudimentary calvarial bones, which do not 
grow beyond the sites of condensations. (Publication I). 
The ch mutants lack functional winged helix/forkhead transcription factor Foxc1 
due to a nonsense point mutation that causes an early stop codon at the amino terminus of 
the DNA binding domain (Kume et al., 1998; Hong et al., 1999). The ch mutant animals 
produce a truncated Foxc1 peptide consisting only of the amino terminal winged helix 
domain. It lacks the central DNA binding domain and carboxyl terminal winged helix 
domain. The lack of the DNA binding domain prevents the truncated Foxc1 peptide to 
bind to any target DNA. The ch mutants have an identical phenotype to Foxc1 knock out 
mice (Kume et al., 1998). The major skeletal phenotype is the rudimentary calvarial bones 
but other skeletal elements are also affected including the ribs, sternum, and cranial base 
bones (Grüneberg, 1943; Grüneberg, 1953; Green, 1970; Kume et al., 1998; Hong et al., 
1999). 
Few years ago, Jiang et al. (2002) demonstrated that mouse calvarium is derived 
from two different origins so that the frontal bones and the dura mater underlying it are 
neural crest-origin, the parietal bones are of mesodermal origin while the dura mater 
underlying them is derived from the neural crest, and the interparietal bone and the 
underlying dura mater are mesodermal. In ch mutant animals the calvarial bones were 
affected similarly despite their differential mesenchymal origin or the origin of the 
underlying dura mater (Fig. 3C, F in Publication I). The initial osteogenic condensations 
form in ch mutants although Grüneberg (1943) showed that their size and shape is altered. 
The condensations for the frontal bones appeared broader and shorter in ch mutants (Fig. 
2B in Publication I) but this may partly be due to a differential plane and angle of 
sectioning in comparison to wild type sections. We showed that in ch mutant calvaria the 
osteogenesis within condensations started at the right spatiotemporal window as indicated 
by the correct timing and location of expression of Msx2, Alx4, Runx2 and Bsp at E13 
(Fig. 2B, 4A-L, 4S-X in Publication I). But the osteogenesis at the growing edges of the 
condensations were suppressed as indicated by the reduced expression of Msx2 and Alx4 
(Fig 4G-J, 4M-P in Publication I). 
The massive hydrocephalus has been thought to prevent the growth of the 
calvarial bones in ch mutants due to increased intracranial pressure (Grüneberg, 1943; 
Kume et al., 1998). In vitro culture free of pressure should rescue the calvarial phenotype, 
at least partly, if the increased intracranial pressure is responsible for the lack of bone 
growth. When calvarial explants from ch mutants were cultured for seven days, their 
calvarial bones did not further their growth (Fig. 3 in Publication I). Further support for 
the intrinsic and primary role for Foxc1 in the calvarial phenotype came from detailed 
analysis of ch heterozygous embryos; they had an enlarged sagittal suture indicating 
delayed ossification (Fig. 3H in Publication I). These results together with the expression 
pattern of Foxc1 in calvarial mesenchyme and in osteoblasts (Fig. 1A-D in Publication I) 
and the reduced expression of osteoprogenitor cell markers Msx2 and Alx4 (Fig. 4 in 
Publication I) support a dosage-sensitive role for Foxc1 in calvarial bone development 
and growth. 
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Msx2 regulates proliferation at the osteogenic fronts of postnatal sutures (Satokata 
et al., 2000), and as Msx2 and Alx4 transgenic animals show calvarial bone defects similar 
to ch mutant animals,. we hypothesized that Foxc1 maintains proliferation of 
osteoprogenitor cells in the early calvarial bones by positively regulating the expression 
of Msx2 and Alx4 in the osteogenic calvarial mesenchyme. To support this hypothesis, we 
showed that the proliferation of osteoprogenitor cells in the forming calvarial bones was 
significantly reduced in ch mutant animals (Fig. 6A and B in Publication I), and that 
Foxc1 was required for Bmp-induction of Msx2 and Alx4 in calvarial mesenchyme (Fig. 
5B in Publication I). What is of special interest and highlights the importance of Msx2 
and Alx4 in regulating the proliferation of osteoprogenitor cell population is that the 
calvarial mesenchyme in ch mutants did not lack osteogenic potential. For instance Msx1 
expression was normal in ch mutants, and it was BMP-inducible in the ch mutant calvarial 
mesenchyme unlike Msx2 and Alx4 (Fig. 4M-R, 5B in Publication I). Also, the expression 
of type I collagen was normal in ch mutant calvarial mesenchyme, as was Twist 
expression that is regulated by Fgf signalling (data not shown, unpublished results). 
Importantly, ectopic FGF2 induced expression of osteopontin, which is expressed by 
osteoblasts, in ch mutant calvarial mesenchyme (Fig. 4, unpublished results). 
 
 
 
 
Figure 4. Induction of osteopontin by rhFGF2 does not require Foxc1. E15 calvarial 
explant of ch mutant shows induction of osteopontin by rhFGF2 bead. This induction 
demonstrates that the calvarial mesenchyme has osteogenic potential in ch mutants. 
 
 
The combination of lack of Msx2 and Alx4 expression and cell proliferation in the 
calvarial mesenchyme in ch mutant animals suggests that Foxc1 plays an important role in 
maintaining osteoprogenitor cells proliferative and thus preventing too early 
differentiation and depletion of osteoprogenitor cells. In support of this, the calvarial 
mesenchyme in the ch mutant animals responded to osteoblast-inducing signals. Similar 
functions have been proposed to other Fox family members: Foxc2 has been shown to 
control the proliferation of sclerotome-derived cells (Winnier et al., 1997), and Foxe3 has 
been shown to be essential for maintaining lens epithelial cell proliferation and preventing 
their premature differentiation (Blixt et al., 2000). 
An intriguing aspect of Foxc1 expression pattern is that although the transcripts 
localized to osteoprogenitor cells and in mature osteoblasts, they were not found in 
osteogenic condensations. One possibility is that osteogenic condensations need to stop 
proliferation to allow differentiation to occur. Another possibility is that Foxc1 
participates in the regulation of adhesive properties or composition of extracellular matrix 
of osteogenic cells. This would not be mutually exclusive with regulation of cell 
proliferation levels. Interestingly, Foxc1 appears to play differential roles in 
chondrogenesis as it is expressed in chondrogenic mesenchymal cells and condensations 
but not in mature chondrocytes. 
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During calvarial bone formation the Bmp signal may arise from both the calvarial 
mesenchyme itself or it may come from the underlying dura mater as at least Bmp2, 4, 
and 7 are expressed in both locations (Fig. 5A in Publication I). Some inductive signals 
originating from dura mater may play a role in directing the growth of calvarial bones 
since their growth in ch mutants appears to have stopped just prior to contact with the 
underlying dura mater (Fig. 3C, F in Publication I). Dura mater and subarachnoid layer of 
the meninges have been reported to be abnormal in ch mutants (Green, 1970; Kume et al., 
1998) yet their meningial layers express Bmps (Fig. 5A in Publication I). Regulating Bmp 
signalling may be a general function of Foxc1 as sternal micromass cultures from ch 
mutants failed to differentiate even with added BMP2 (Kume et al., 1998). 
Foxc1 and a closely related gene Foxc2 have distinct yet extensively overlapping 
expression patterns in neural crest and paraxial mesoderm and in their derivatives 
(Hiemisch et al., 1998; Publication I). Null allele Foxc2 animals show a phenotype that is 
both similar to and different from the phenotype of Foxc1 mutant animals: the main 
difference is that the appendicular skeleton and the sternum are intact in Foxc2 mutants 
while they are affected in Foxc1 mutants; Foxc2 mutants exhibit a complete cleft of the 
secondary palate while Foxc1 mutants have not been reported to have any defects in their 
palatal development; and importantly, no calvarial abnormalities have been reported in 
Foxc2 animals (Iida et al., 1997; Winnier et al., 1997; Kume et al., 1998; Hong et al., 
1999). Studies on compound heterozygous Foxc1+/-;Foxc2+/- embryos during heart, 
kidney, eye, and somite development has shown that Foxc1 and Foxc2 have similar, dose-
dependent functions, and that they can compensate for each other (Kume et al., 2000, 
2001; Smith et al., 2000). In double heterozygous Foxc1+/-;Foxc2+/- animals no gross 
malformations have been detected in the developing skeleton indicating that these genes 
do not interact during skeletogenesis (Winnier et al., 1999). The compound homozygous 
Foxc1-/-;Foxc2-/- animals have a very small first branchial arch, and they lack second 
branchial arch and segmented paraxial mesoderm (Kume et al., 2001). Severe defects in 
the first and second branchial arches indicate that facial skeleton would be defective, and 
that both Foxc1 and Foxc2 function during facial development. Skeletal phenotype in 
compound homozygous animals can not be studied as these embryos die at E9.0 - 9.5 due 
to heart failure (Kume et al., 2001). Although the expression patterns of Foxc1 and Foxc2 
are extensively overlapping during embryonic development, we have shown that Foxc2 
was not expressed in the calvarial mesenchyme and thus can not compensate for the lack 
of Foxc1 in that tissue (Fig. 1 in Publication I). Foxc2 was expressed in the dura mater 
together with Foxc1 (Fig. 1 in Publication I). 
Publication I showed that Foxc1 regulates Bmp signalling but Foxc1 itself does 
not appear to be a positive downstream target of Bmp signalling as BMP beads in the 
calvarial mesenchyme at E15 did not induce expression of Foxc1 (data not shown). Foxc 
genes have been shown to be under Shh regulation in the developing head mesenchyme at 
E9 and to direct expression of Tbx1 in the developing facial structures and the aortic arch 
(Yamagishi et al., 2003). Mahlapuu and her colleagues (Mahlapuu et al., 2001) 
demonstrated that Shh null allele animals lack expression of Foxf1 in the developing lung, 
and that Shh-secreting cell pellets on lung mesenchyme activated the expression of Foxf1. 
Furthermore, Mahlapuu et al. (2001) showed that lung epithelial Bmp signalling 
negatively regulates the mesenchymal expression of Foxf1, and that Fgf signalling 
inhibits the expression of Foxf1 by inhibiting Shh signalling (FGF7) and by activating 
Bmp signalling (FGF10). Both of these Fgf ligands use the epithelial receptor Fgfr2b 
(Mahlapuu et al., 2001). In the mouse calvarium, the major Fgf receptor isoform has been 
shown to be Fgfr2c during suture formation (Kim et al., 1998; Rice et al., 2000; 
Publication II). Fgf signalling can activate Bmp signalling during suture fusion by 
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suppressing the expression of Bmp antagonist noggin (Warren et al., 2003). Hedgehog 
signalling has also been shown to play a role during suture fusion (Kim et al., 1998). 
Presently, I am investigating possible roles for Foxc1 as a link between Fgf, Hh, and Bmp 
signalling during calvarial development. 
 
Isoform-specific Fgfr expression patterns in craniofacial skeleton during 
development (Publication II) 
To understand where Fgf signalling pathway may function during development, it is 
essential to study the tissue localization of the receptors in detail. Four different Fgf 
receptor genes (Fgfr1-4) have been identified of which receptors 1-3 show alternative 
splicing that creates different receptor isoforms. Especially, the alternative splicing at the 
coding region of the extracellular ligand-binding immunoglobulin-like domain III changes 
the expression domain and the ligand specificity of the receptor isoform so that the same 
gene yields two different receptors: the epithelial IIIb and mesenchymal IIIc isoforms 
(Kannan and Givol, 2000; Ornitz and Marie, 2002). Recognizing differential or 
overlapping expression patterns of Fgfr isoforms is important when aiming to understand 
human pathological conditions caused by gain-of-function mutations in different FGFR 
isoforms. These mutations can cause ligand-independent dimerization of the receptor and 
thus activate signalling; they can extend the duration of the signalling, alter ligand 
specificity, or cause isoform switching (Ornitz and Marie, 2002.). 
In the craniofacial region, the Fgfr isoform expression patterns have been 
carefully studied during molar (Kettunen et al., 1998) and sagittal suture (Kim et al., 
1998; Rice et al., 2000) development in the Thesleff laboratory. Coronal sutures have 
been shown to express Fgfrs (Iseki et al., 1997) but this study did not distinguish between 
b and c isoforms. In Publication II we showed that also coronal and lambdoidal sutures 
express Fgfr isoforms in the same pattern as sagittal suture: the proliferative preosteoblast 
cell population in osteogenic fronts of the calvarial bones express mainly Fgfr2c, with 
weaker intensity Fgfr1c, and very weakly Fgfr2b (Fig. 6 in Publication II). Based on the 
Fgfr isoform expression patterns, it appears that all established calvarial sutures utilise 
Fgf signalling similarly through Fgfr2c and Fgfr1c. 
Craniosynostosis patients exhibit multiple skeletal malformations including 
abnormalities in the limbs, cranial base and face (Wilkie and Morriss-Kay, 2001). Thus, 
we also detailed Fgfr expression patterns in cranial base synchondroses, mandibular 
condyle, body and alveolus. Synchondroses are growth sites where endochondral 
ossification regulates the growth of the cranial base bones. Fgfr1c was expressed only by 
osteoblast-forming cells in the erosive zones of the synchondroses while Fgfr2b and 
Fgfr2c had overlapping expression patterns in the periosteum and perichondrium 
suggesting paracrine mode of function for chondrocytes (Fig. 3A-D in Publication II). 
Fgfr2b and Fgfr2c were also expressed very weakly by the resting and proliferative 
chondrocytes (Fig. 3A-D in Publication II). Fgfr3b and c isoforms were expressed by 
prehypertrophic and hypertrophic chondrocytes so that the Fgfr3b transcript domain was 
more restricted than that of Fgfr3c (Fig. 3E-F in Publication II). This expression pattern 
suggests that Fgfr3 isoforms play a cell-autonomous role in the function of chondrocytes. 
Similar expression domains were seen in mandibular condyle, which is a secondary 
cartilage that functions as a joint connecting the mandible to the temporal bone: Fgfr2 
isoforms in the perichondrium and Fgfr3 isoforms in the (pre)hypertrophic chondrocytes 
(Fig. 4 in Publication II). It is of interest to note that the expression pattern of Fgfrs in 
synchondroses and mandibular condyles is similar to that in growth plates in long bones 
(reviewed in Ornitz and Marie, 2002). 
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Wang et al. (2001) demonstrated in ColII-Fgfr3ach transgenic mice that 
suppression of mitogenic activity by Fgf signalling is a unique property of growth plate 
chondrocytes. As chondrocytes in synchondroses and growth plates express Fgfrs in a 
similar pattern we suggest that some of the cranial base malformations, such as short 
cranial base or premature fusion of synchondrosis, in craniosynostosis patients arise by 
similar mechanisms as their limb phenotypes. 
Fgfr expression pattern was shown to be the same in all calvarial sutures despite 
their tissue origins, and the same was true for cranial base synchondroses (Figs 3 and 6 in 
Publication II). For instance the basioccipital synchondrosis is between the somitomere-
derived occipital bone and the paraxial mesoderm-derived basisphenoid bone, and 
intersphenoidal synchondrosis is between the paraxial mesoderm-derived basisphenoid 
bone and the cranial neural crest-derived presphenoid bone (Couly et al., 1993). 
The expression patterns studied in Publication II help to explain various 
craniofacial malformations found in patients with FGFR mutations. Overlapping 
expression of b and c isoforms by the same cell population in the developing calvarial 
sutures and cranial base synchondrosis allows usage of multiple ligands, especially if a 
mutation has caused aberrant isoform switching. This has been shown to be the case in 
Fgfr2c hemizygous mice in which partial inactivation of an exon specific to the Fgfr2c 
isoform caused ectopic activation of the Fgfr2b isoform (Hajihosseini et al., 2001). 
Interestingly, Pro250Arg mutation in Fgfr1, which causes craniosynostosis, does 
not cause any significant differences in long bones or synchondroses (Zhou et al., 2000). 
The mutation may be specific to osteoblast lineage or intramembranous ossification. This 
is supported by our Fgfr expression pattern analysis in various craniofacial structures 
which indicated that Fgfr1 was only expressed by osteoblast-forming cell populations and 
not by chondrocytes. 
 
Fgf signalling is essential for palatal shelf outgrowth (Publication III) 
Fgf signalling has been shown to direct the distal outgrowth of facial prominences in 
chick (Richman et al., 1997). The vertebrate face develops through frontonasal, two 
lateral nasal, two maxillary, and two mandibular prominences that are mesenchymal buds 
surrounded by ectoderm. Palatal shelves again are outgrowths of the two maxillary 
prominences (Ferguson, 1998). 
We used Fgf10 and Fgfr2b null allele animals, which both exhibit cleft palate 
(Publication III and De Moerlooze et al., 2000, respectively), as model systems to study 
the role of Fgf signalling in palatal development. Both mutant animals exhibited a wide 
cleft of the secondary palate so that anterior and posterior palate were equally affected at 
birth (Fig. 1A-C in Publication III). We first identified abnormalities in the development 
of secondary palatal shelves in these mutants at E13 when the morphology of the palatal 
shelves was short and square, and the epithelium was thin and non-stratified (Fig. 1D-I in 
Publication III). Both in the Fgf10 and Fgfr2b null allele animals the stubby palatal 
shelves elevated to a horizontal position correctly but were too short to meet with each 
other at the midline. To study whether the mutant palatal shelves were able to fuse, we 
placed palatal shelves from Fgfr2b null allele litter next to each other in a correct anterior-
posterior orientation in organ culture. All genotypes fused in culture and showed a 
continuous mesenchyme, which indicated that fusion had been complete (data not shown). 
This ruled out the possibility of defective palatal shelf fusion being responsible for the 
cleft palate. 
 We analyzed the expression patterns of Fgfr2b and its ligands Fgf10, Fgf7, and 
Fgf3 during palatal development. Fgf22 is also a ligand for Fgfr2b but it is not expressed 
before E16.5 in mouse embryos (Beyer et al., 2003). This is after palatal shelves have 
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fused, and thus its expression pattern was not analyzed. Fgfr2b was expressed in the 
epithelium while ligands were expressed in the mesenchyme (Fig. 2 in Publication III and 
data not shown). Fgf3 was not expressed in the developing palate, but Fgf7 and Fgf10 
showed a differential mesenchymal expression pattern so that Fgf10 expression was found 
mainly in the mesenchyme adjacent to the oral epithelium, and the expression of Fgf7 was 
restricted to the mesenchyme adjacent the nasal epithelium until E14 when it was also 
expressed in the mesenchyme adjacent to the oral epithelium. As nasal and oral 
epithelium in palatal shelves differ from each other it is possible that Fgf7 and Fgf10 may 
play a role in setting this difference. Fgf10 transcripts were also found in the mesenchyme 
in the ‘bend’ region on the nasal side of the developing palate. Thus, overlapping 
expression domains for Fgf7 and Fgf10 were the ‘bend’ region and the medial edge 
epithelial region (Fig. 6 in Publication III). These expression patterns support a specific 
function for Fgf signalling in the palatal development. 
Previously Fgf10 and Fgfr2b null allele animals have been studied in detail during 
limb and lung development (Min et al., 1998; Sekine et al., 1999; De Moerlooze et al., 
2000; Revest et al., 2001). These studies demonstrated that Fgf10/Fgfr2b signalling 
pathway regulates cell proliferation, apoptosis and survival, and that it is required for 
outgrowth of a bud through epithelial-mesenchymal interactions. We studied these 
mutants for possible changes in the level of proliferation in the palate (Fig. 3 and 4 in 
Publication III). It is of interest to note that in wild type animals at E12 and E13, the 
posterior MEE region had more proliferative cells than the anterior MEE region. The 
palatal mesenchyme reflected the same results (Fig. 3 in Publication III). Similarly, 
cranial base bones have been shown to have a posterior to anterior growth gradient 
(Roberts and Blackwood, 1984). In both mutants the epithelial cell proliferation was 
reduced significantly while cell proliferation was reduced only slightly in the 
mesenchyme. As Fgf10 signals from the mesenchyme to its receptor in the epithelium, it 
made sense that the level of proliferation was affected in the epithelium. The reduction in 
the level of mesenchymal cell proliferation suggested that there may be a signal coming 
back to mesenchyme from the epithelium to maintain its survival and proliferation. To 
confirm that Fgf10 plays a proliferative role in the developing palate, we placed FGF10-
containing beads on the epithelium of palatal explants cultured in isolation. Ectopic 
FGF10 induced proliferation in the epithelium and also to a lesser extent in the underlying 
mesenchyme (Fig. 5 in Publication III). 
We also performed TUNEL analysis on the mutants to test whether cell survival 
was altered when Fgf10/Fgfr2b signalling was blocked. In wild type animals prior to E14 
there were no apoptotic cells in the oral epithelium while mutants showed isolated areas 
of TUNEL-positive, apoptotic cells in the patches of thickened epithelium already at E13 
(Fig. 4 in Publication III). This suggested that Fgf10/Fgfr2b signalling pathway maintains 
outgrowth of the palatal shelves by acting both as a proliferative and a survival factor. 
Fgf10/Fgfr2b signalling has been shown to regulate the expression of Shh in limb 
buds (Sekine et al., 1999; Revest et al., 2001). Similarly, we showed that Shh is a 
downstream target of Fgf10/Fgfr2b signalling in the epithelium of the developing palate 
as its expression was downregulated in the palatal epithelium in both Fgf10 and Fgfr2b 
null allele animals (Fig. 5D-I in Publication III), and FGF10-containing beads induced 
expression of Shh in the palatal epithelium (Fig. 5B-C in Publication III). To study the 
role of Shh in the early palatal development, and especially to see whether it has a 
reiterative effect back to the palatal mesenchyme, we placed human recombinant SHH-
containing beads on palatal explants in culture. SHH-containing beads induced 
proliferation in the palatal mesenchyme (Fig. 5, Publication III). To further support the 
role of Shh regulating mesenchymal proliferation, we demonstrated that patched (Ptc), the 
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receptor of Shh, was not expressed in the palatal epithelium but in the mesenchyme. 
Interestingly, also FGF10-containing beads were sufficient to induce Ptc expression in the 
mesenchyme (Fig. 5, Publication III). These results further support our hypothesis that 
Shh is a downstream target of Fgf10/Fgfr2b signalling in the early palate, and that this 
signalling network is responsible for the growth and survival of the epithelium and 
mesenchyme in the palatal shelves. 
The mesenchymal Bmp4/Msx1 signalling has been shown to induce Shh 
expression in the palatal epithelium (Zhang et al., 2002). Thus, it appears that Shh is under 
complex regulation by both Bmp and Fgf signalling pathways during palatal shelf growth. 
Further support for Shh signalling regulating mesenchymal proliferation and survival 
and/or differentiation in the developing palate comes from transgenic animals lacking Shh 
specifically in the epithelia (K-14Cre;Shhc/n, Dassule et al., 2000). These conditional Shh 
null allele animals exhibited a complete cleft palate similar to Fgf10-/- or Fgfr2b-/- 
animals (Fig. 5I-J in Publication III). The role of Shh as a mesenchymal regulator was 
emphasized in transgenic animals where a Shh downstream signalling target smoothened 
(Smo) was removed from epithelia (K-14Cre;Smoc/n, Gritli-Linde et al., 2002). These 
animals had normal palatal development (data not shown). 
 Taken together, we have shown that palatal epithelium functions to direct growth 
and survival of the adjacent mesenchyme. This signalling requires a network that 
combines Fgf10/Fgfr2b and Shh signalling. 
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CONCLUSIONS 
 
The publications composing this thesis were aimed at looking early stages of craniofacial 
bone and palate development and how their growth is regulated. I have shown that the 
level of proliferation in the progenitor cell populations is an important factor in the 
growth and patterning of an organ as either calvarial bones or palatal shelves will not 
develop if level of proliferation is altered. Proliferation is regulated by growth factor 
signalling so that an accurate balance of proliferation and differentiation is achieved in the 
appropriate progenitor cell populations. 
 I have demonstrated a novel role for transcription factor Foxc1 in controlling Bmp 
regulation of transcription factors Msx2 and Alx4 in calvarial mesenchyme, and how this 
regulation is needed for proliferation of osteoprogenitor cells in early calvarial bones. 
There are still many unanswered questions. What regulates Foxc1? Does Foxc1 regulate 
Bmp signalling through contact with Smads? What is the role of Foxc1 in the developing 
meninges and does this relate to calvarial bone formation? 
 I have also shown that the outgrowth and morphogenesis of the palatal shelves are 
regulated and maintained through reiterative Fgf and Shh signalling networks in palatal 
buds. This work raises the developing palate into the category of organs where 
morphogenesis starts as a bud, and the growth is patterned through network of growth 
factor signals that dart back and forth between the epithelium and mesenchyme. It will be 
exciting to see in the future whether the differential expression of Fgf7 and Fgf10 
determines the nasal and oral epithelium in the developing palatal shelves, and why they 
are coexpressed in the medial edge epithelium and the ‘bend’ region. Could there be some 
signalling centre function in these locations? 
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